MACM
TMO icon

March Altus Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

March Altus Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-51,545
Closed -$5.74M – 35
2013
Q4 		$5.74M Buy
+51,545
New +$5.13M 1.74% 26

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

March Altus Capital Management's TMO Position: Q1 2014 in Review

March Altus Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2014, closing a stake of 51,545 shares — an estimated $5.74M sold.

March Altus Capital Management first reported a position in TMO in Q4 2013 and held it in 1 quarter. The position peaked at $5.74M in Q4 2013. 915 funds tracked by Wall St. Rank hold TMO as of Q1 2014.

  • March Altus Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2014 after selling out during the quarter.
  • March Altus Capital Management sold 51,545 Thermo Fisher Scientific shares in Q1 2014, an estimated $5.74M.
  • March Altus Capital Management first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 1 quarter.
  • March Altus Capital Management's Thermo Fisher Scientific position peaked at $5.74M in Q4 2013.
  • 915 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2014.

Based on March Altus Capital Management's 13F filing for Q1 2014, filed 15 May 2014.